Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells
- PMID: 2438376
- DOI: 10.1099/0022-1317-68-6-1575
Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells
Abstract
Monoclonal antibodies specific for the 'latent membrane protein' (LMP) of Epstein-Barr virus (EBV), one of the effector proteins of EBV-induced B cell transformation, have been generated from mice immunized with a beta-galactosidase fusion protein containing the carboxyl half of the B95.8 strain LMP sequence. Four monoclonal IgG1 antibodies, designated CS.1, CS.2, CS.3 and CS.4, which together recognized at least three different epitopes on the molecule, were used to examine various aspects of LMP expression in B cell lines transformed in vitro. The pooled CS.1 to 4 reagent detected the LMPs encoded by each of 20 geographically distinct EBV isolates, despite a degree of inter-isolate heterogeneity in the size and antigenicity of the protein. In cell lines carrying the prototype B95.8 virus strain, particularly if these were virus producers, an additional lower molecular weight LMP was also detected; this appeared to correspond to the truncated form of the protein already predicted to exist from the analysis of B95.8 lytic cycle mRNAs. Attempts were made to identify an analogous truncated form of LMP in cell lines carrying other virus isolates after treatment with phorbol ester and/or sodium butyrate to induce virus production. Surprisingly these experiments showed that expression of the full length LMP molecule was itself strongly inducible by these agents; when monitored at the single cell level, this was a generalized response and was not restricted to cells entering a lytic cycle. Expression of LMP in EBV-transformed B cells therefore appears to be subject to a distinct type of regulation.
Similar articles
-
Early detection of the lytic LMP-1 protein in EBV-infected B-cells suggests its presence in the virion.Virology. 1997 Jul 21;234(1):1-13. doi: 10.1006/viro.1997.8638. Virology. 1997. PMID: 9234942
-
Epstein-Barr virus gene expression in nasopharyngeal carcinoma.J Gen Virol. 1988 May;69 ( Pt 5):1051-65. doi: 10.1099/0022-1317-69-5-1051. J Gen Virol. 1988. PMID: 2836550
-
Expression of the Epstein-Barr virus (EBV)-encoded membrane antigen (LMP) increases the stimulatory capacity of EBV-negative B lymphoma lines in allogeneic mixed lymphocyte cultures.Eur J Immunol. 1990 Oct;20(10):2293-9. doi: 10.1002/eji.1830201019. Eur J Immunol. 1990. PMID: 2173662
-
Immunohistochemical detection of Epstein-Barr virus-encoded latent membrane protein in Reed-Sternberg cells and variants of Hodgkin's disease.Mod Pathol. 1994 May;7(4):454-61. Mod Pathol. 1994. PMID: 7520586 Review.
-
Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1.Immunol Lett. 2006 Apr 15;104(1-2):83-8. doi: 10.1016/j.imlet.2005.11.003. Epub 2005 Dec 1. Immunol Lett. 2006. PMID: 16386314 Review.
Cited by
-
(-)-Epigallocatechin-3-gallate inhibition of Epstein-Barr virus spontaneous lytic infection involves downregulation of latent membrane protein 1.Exp Ther Med. 2018 Jan;15(1):1105-1112. doi: 10.3892/etm.2017.5495. Epub 2017 Nov 13. Exp Ther Med. 2018. PMID: 29399111 Free PMC article.
-
Persistent Epstein-Barr virus infection in a human T-cell line: unique program of latent virus expression.EMBO J. 1995 Aug 1;14(15):3706-11. doi: 10.1002/j.1460-2075.1995.tb00040.x. EMBO J. 1995. PMID: 7641689 Free PMC article.
-
High expression of the Epstein-Barr virus latent protein EB nuclear antigen-2 on pyothorax-associated lymphomas.Am J Pathol. 1993 Nov;143(5):1280-5. Am J Pathol. 1993. PMID: 8238246 Free PMC article.
-
Viruses and cancer risks: outgrowth of Epstein-Barr virus-positive Burkitt's lymphoma in the immune host.Med Oncol Tumor Pharmacother. 1987;4(3-4):177-86. doi: 10.1007/BF02934513. Med Oncol Tumor Pharmacother. 1987. PMID: 2831439
-
A novel latent membrane 2 transcript expressed in Epstein-Barr virus-positive NK- and T-cell lymphoproliferative disease encodes a target for cellular immunotherapy.Blood. 2010 Nov 11;116(19):3695-704. doi: 10.1182/blood-2010-06-292268. Epub 2010 Jul 29. Blood. 2010. PMID: 20671118 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources